GLOBALT Investments LLC GA Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GLOBALT Investments LLC GA boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 656.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,809 shares of the medical equipment provider’s stock after buying an additional 5,909 shares during the quarter. GLOBALT Investments LLC GA’s holdings in Intuitive Surgical were worth $3,345,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Mirador Capital Partners LP boosted its position in shares of Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. lifted its position in Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after buying an additional 1,129 shares during the last quarter. Consolidated Planning Corp boosted its stake in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the last quarter. Finally, ABLE Financial Group LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at about $604,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several analyst reports. Leerink Partners lifted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Stifel Nicolaus boosted their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, BTIG Research set a $535.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $527.61 on Monday. The company has a market cap of $187.92 billion, a P/E ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39. The stock has a 50-day moving average of $499.29 and a two-hundred day moving average of $458.50. Intuitive Surgical, Inc. has a 1-year low of $295.02 and a 1-year high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.